A nurse is reinforcing teaching to a group of high school students about how penetrating traumatic brain injuries cause damage to the brain. Which of the following statements should the nurse include in the teaching?

The Glasgow Coma Scale (GCS) is a standardized neurological tool used to assess level of consciousness, evaluating eye opening, verbal response, and motor response. A declining score reflects worsening cerebral function, often due to increased intracranial pressure or evolving brain injury.

Rationale:

A. A decrease from 14 to 10 is not a normal finding. Normal neurological status is reflected by stable or improving GCS scores. A drop indicates deterioration in cortical or brainstem function, often linked to hypoxia, hemorrhage, or increased intracranial pressure progression.

B. A declining GCS score does not represent a stable condition. Stability requires no change or minimal fluctuation in neurological status. A drop of 4 points is clinically significant and suggests ongoing neurological compromise requiring immediate reassessment and possible escalation of care.

C. A reduction in GCS from 14 to 10 is not an improvement. Improvement would involve an increasing score indicating better eye, verbal, and motor responses. The observed decrease reflects reduced consciousness and impaired neurological responsiveness rather than recovery.

D. A falling GCS score indicates worsening neurological status. This change suggests progressive cerebral dysfunction potentially due to intracranial bleeding, hypoxia, or brain edema. It is a critical deterioration requiring urgent neurological evaluation and possible emergency intervention to prevent further decline.

Diabetic peripheral neuropathy is a chronic microvascular and metabolic complication of diabetes mellitus caused by prolonged hyperglycemia leading to axonal degeneration, demyelination, and ischemic injury of peripheral nerves. It commonly presents with distal symmetric sensory loss, burning pain, and paresthesia, especially in the lower extremities.

Rationale:

A. Age-related reduced perfusion may contribute to vascular insufficiency but does not explain diabetic neuropathy pathophysiology. Peripheral neuropathy in diabetes is primarily driven by metabolic and microvascular injury rather than physiologic aging changes affecting distal limb circulation alone.

B. Chronic hyperglycemia leads to non-enzymatic glycation of proteins, oxidative stress, and microvascular ischemia causing nerve damage in diabetic peripheral neuropathy. Sustained elevated glucose disrupts Schwann cell function and axonal conduction, producing sensory symptoms such as burning, tingling, and nocturnal pain.

C. Peripheral neuropathy is not caused by temporary functional sleep of nerves or interruption between brain and spinal cord signaling. It results from structural nerve injury due to metabolic and ischemic mechanisms rather than reversible conduction block or positional neural inactivity.

D. Diabetic neuropathy is not idiopathic in uncontrolled diabetes mellitus. It has a well-established pathophysiology involving chronic hyperglycemia-induced microvascular injury and metabolic toxicity. Although some neuropathies are idiopathic, diabetic neuropathy has a clearly defined causal mechanism.